Cancer Control and Population Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City2College of Nursing, University of Utah, Salt Lake City3Health Services and Economics Branch, National Cancer Institute, National Institutes of Health, Ro.
Health Services and Economics Branch, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
JAMA Intern Med. 2014 Feb 1;174(2):293-6. doi: 10.1001/jamainternmed.2013.12607.
Leading national organizations are increasingly using evidence-based recommendations for Papanicolaou testing. As of 2003, organizations recommended against Papanicolaou testing for women without a cervix following a hysterectomy who do not have a history of high-grade precancerous lesion or cervical cancer and for women older than 65 years with adequate prior screening and who are not at high risk. Few studies have investigated overuse of Papanicolaou testing among US women. We aimed to investigate overuse of Papanicolaou testing in relation to cervical cancer screening recommendations.
主要的国家组织越来越多地使用基于证据的巴氏涂片检测建议。截至 2003 年,对于因子宫切除而没有子宫颈的、没有高级别癌前病变或宫颈癌病史的女性,以及对于年龄超过 65 岁且有充分的既往筛查且不属于高风险的女性,组织不建议进行巴氏涂片检测。很少有研究调查了美国女性巴氏涂片检测过度使用的情况。我们旨在调查与宫颈癌筛查建议相关的巴氏涂片检测过度使用的情况。